Protective effects of clenbuterol against dexamethasone-induced masseter muscle atrophy and myosin heavy chain transition

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Umeki, Daisuke ^a   Ohnuki, Yoshiki ^a   Mototani, Yasumasa ^a   Shiozawa, Kouichi ^a   Suita, Kenji ^b   Fujita, Takayuki ^b   Nakamura, Yoshiki ^a   Saeki, Yasutake ^a   Okumura, Satoshi ^a,b  

^a TSURUMI UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CALCINEURIN; CLENBUTEROL; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MYOSIN HEAVY CHAIN; MYOSTATIN; PROTEIN KINASE B; SERINE; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; ISOPROTEIN; MESSENGER RNA; MUSCLE PROTEIN; PHOSPHOSERINE; PROTECTIVE AGENT; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FAST TO SLOW PROTEIN ISOFORM TRANSITION; HEART MUSCLE; IMMUNOBLOTTING; MASSETER MUSCLE; MUSCLE ATROPHY; MUSCLE CROSS SECTIONAL AREA; MUSCLE FIBER DIAMETER; MUSCLE MASS; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; RAT; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; ABNORMALITIES; ANIMAL; DRUG EFFECTS; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HYPERTROPHY; METABOLISM; MUSCULAR ATROPHY; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; PHOSPHORYLATION; WISTAR RAT;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CLENBUTEROL; DEXAMETHASONE; ENERGY METABOLISM; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; HYPERTROPHY; INSULIN-LIKE GROWTH FACTOR I; MASSETER MUSCLE; MUSCLE PROTEINS; MUSCULAR ATROPHY; MYOSIN HEAVY CHAINS; ORGAN SIZE; PHOSPHORYLATION; PHOSPHOSERINE; PROTECTIVE AGENTS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84936817485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128263     Document Type: Article

References (49)

1. Pereira RM, Freire de Carvalho J (2011) Glucocorticoid-induced myopathy. Joint Bone Spine 78: 41-44. doi: 10.1016/j.jbspin.2010.02.025 PMID: 20471889
2. Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP (2013) Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol 45: 2163-2172. doi: 10.1016/j.biocel.2013.05.036 PMID: 23806868
3. Nakamura S, Kawai N, Ohnuki Y, Saeki Y, Korfage JA, Langenbach GE, et al. (2013) Changes in activity and structure of jaw muscles in Parkinson's disease model rats. J Oral Rehabil 40: 205-213. doi: 10.1111/joor.12030 PMID: 23331038
4. Agbenyega ET, Wareham AC (1992) Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone. Comp Biochem Physiol Comp Physiol 102: 141-145. PMID: 1351811
5. Ohnuki Y, Umeki D, Cai W, Kawai N, Mototani Y, Shiozawa K, et al. (2013) Role of masseter muscle β2-adrenergic signaling in regulation of muscle activity, myosin heavy chain transition, and hypertrophy. J Pharmacol Sci 123: 36-46. PMID: 23985574
6. Pellegrino MA, D'Antona G, Bortolotto S, Boschi F, Pastoris O, Bottinelli R, et al. (2004) Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice. Exp Physiol 89: 89-100. PMID: 15109214
7. Jiang TX, Cairns A, Road JD, Wilcox PG (1996) Effect of the beta-agonist clenbuterol on dexamethasone-induced diaphragm dysfunction in rabbits. Am J Respir Crit Care Med 154: 1778-1783. PMID: 8970370
8. Huang H, Gazzola C, Pegg GG, Sillence MN (2000) Differential effects of dexamethasone and clenbuterol on rat growth and on β2-adrenoceptors in lung and skeletal muscle. J Anim Sci 78: 604-608. PMID: 10764067
9. Abo T, Iida RH, Kaneko S, Suga T, Yamada H, Hamada Y, et al. (2012) IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β2-adrenergic agonist. Cell Biochem Funct 30: 671-676. doi: 10.1002/cbf.2848 PMID: 22696074
10. Ricart-Firinga C, Stevens L, Canu MH, Nemirovskaya TL, Mounier Y (2000) Effects of β2-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat. Am J Physiol Cell Physiol 278: C582-588. PMID: 10712247
11. Stevens L, Firinga C, Gohlsch B, Bastide B, Mounier Y, Pette D (2000) Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. Am J Physiol Cell Physiol 279: C1558-C1563. PMID: 11029303
12. Lynch GS, Ryall JG (2008) Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev 88: 729-767. doi: 10.1152/physrev.00028.2007 PMID: 18391178
13. Umeki D, Ohnuki Y, Mototani Y, Shiozawa K, Fujita T, Nakamura Y, et al. (2013) Effects of chronic Akt/mTOR inhibition by rapamycin on mechanical overload-induced hypertrophy and myosin heavy chain transition in masseter muscle. J Pharmacol Sci 122: 278-288. PMID: 23902989
14. Okumura S, Fujita T, Cai W, Jin M, Namekata I, Mototani Y, et al. (2014) Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses. J Clin Invest 124: 2785-2801. doi: 10.1172/JCI64784 PMID: 24892712
15. Kiliaridis S, Engstrom C, Thilander B (1988) Histochemical analysis of masticatory muscle in the growing rat after prolonged alteration in the consistency of the diet. Arch Oral Biol 33: 187-193. PMID: 3178538
16. Ohnuki Y, Umeki D, Mototani Y, Jin H, Cai W, Shiozawa K, et al. (2014) Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation. J Physiol 592: 5461-5475. doi: 10.1113/jphysiol.2014.282996 PMID: 25344550
17. Ohnuki Y, Kawai N, Tanaka E, Langenbach GE, Tanne K, Saeki Y (2009) Effects of increased occlusal vertical dimension on daily activity and myosin heavy chain composition in rat jaw muscle. Arch Oral Biol 54: 783-789. doi: 10.1016/j.archoralbio.2009.05.008 PMID: 19524215
18. Yu H, He Y, Zhang X, Peng Z, Yang Y, Zhu R, et al. (2011) The rat IgGFcãBP and Muc2 C-terminal domains and TFF3 in two intestinal mucus layers bind together by covalent interaction. PLoS One 6: e20334. doi: 10.1371/journal.pone.0020334 PMID: 21629776
19. Okumura S, Tsunematsu T, Bai Y, Jiao Q, Ono S, Suzuki S, et al. (2008) Type 5 adenylyl cyclase plays a major role in stabilizing heart rate in response to microgravity induced by parabolic flight. J Appl Physiol (1985) 105: 173-179. doi: 10.1152/japplphysiol.01166.2007 PMID: 18450980
20. Bai Y, Tsunematsu T, Jiao Q, Ohnuki Y, Mototani Y, Shiozawa K, et al. (2012) Pharmacological stimulation of type 5 adenylyl cyclase stabilizes heart rate under both microgravity and hypergravity induced by parabolic flight. J Pharmacol Sci 119: 381-389. PMID: 22850613
21. Okumura S, Suzuki S, Ishikawa Y (2009) New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: effects of targeted disruption of the type 5 adenylyl cyclase gene. J Pharmacol Sci 109: 354-359. PMID: 19270422
22. Okumura S, Kawabe J, Yatani A, Takagi G, Lee MC, Hong C, et al. (2003) Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circ Res 93: 364-371. PMID: 12869393
23. Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, et al. (2003) Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A 100: 9986-9990. PMID: 12904575
24. Dasarathy S, Dodig M, Muc SM, Kalhan SC, McCullough AJ (2004) Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat. Am J Physiol Gastrointest Liver Physiol 287: G1124-G1130. PMID: 15256363
25. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL (2004) IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287: E591-E601. PMID: 15100091
26. Arai C, Ohnuki Y, Umeki D, Saeki Y (2005) Effects of bite-opening and cyclosporin A on the mRNA levels of myosin heavy chain and the muscle mass in rat masseter. Jpn J Physiol 55: 173-179. PMID: 16080800
27. Moore NG, Pegg GG, Sillence MN (1994) Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration. Am J Physiol 267: E475-E484. PMID: 7943228
28. McElligott MA, Barreto A Jr., Chaung LY (1989) Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle. Comp Biochem Physiol C 92: 135-138. PMID: 2566434
29. Miller MF, Garcia DK, Coleman ME, Ekeren PA, Lunt DK, Wagner KA, et al. (1988) Adipose tissue, longissimus muscle and anterior pituitary growth and function in clenbuterol-fed heifers. J Anim Sci 66: 12-20. PMID: 3366701
30. Deyl Z, Juricova M, Stuchlikova E (1975) The effect of nutritional regimes upon collagen concentration and survival of rats. Adv Exp Med Biol 53: 359-369. PMID: 1119345
31. Tucker MJ (1979) The effect of long-term food restriction on tumours in rodents. Int J Cancer 23: 803-807. PMID: 468413
32. Macedo AG, Krug AL, Herrera NA, Zago AS, Rush JW, Amaral SL (2014) Low-intensity resistance training attenuates dexamethasone-induced atrophy in the flexor hallucis longus muscle. J Steroid Biochem Mol Biol 143: 357-364. doi: 10.1016/j.jsbmb.2014.05.010 PMID: 24861267
33. Roy RR, Gardiner PF, Simpson DR, Edgerton VR (1983) Glucocorticoid-induced atrophy in different fibre types of selected rat jaw and hind-limb muscles. Arch Oral Biol 28: 639-643. PMID: 6579895
34. Taylor DR, Hancox RJ (2000) Interactions between corticosteroids and β agonists. Thorax 55: 595-602. PMID: 10856321
35. Rozengurt E (2014) Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells. Front Physiol 5: 357. doi: 10.3389/fphys.2014.00357 PMID: 25295009
36. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, et al. (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280: 2737-2744. PMID: 15550386
37. Fuentes EN, Ruiz P, Valdes JA, Molina A (2012) Catabolic signaling pathways, atrogenes, and ubiquitinated proteins are regulated by the nutritional status in the muscle of the fine flounder. PLoS One 7: e44256. PMID: 23024748
38. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, et al. (1998) A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12: 2499-2509. PMID: 9716403
39. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD (2000) A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 20: 6600-6611. PMID: 10938134
40. Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN (2000) Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 275: 4545-4548. PMID: 10671477
41. Arai C, Ohnuki Y, Umeki D, Hirashita A, Saeki Y (2006) Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter. J Physiol Sci 56: 205-209. PMID: 16839454
42. Schiaffino S, Reggiani C (1996) Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 76: 371-423. PMID: 8618961
43. Peters MJ, Adcock IM, Brown CR, Barnes PJ (1995) β-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 289: 275-281. PMID: 7621901
44. Oddera S, Silvestri M, Testi R, Rossi GA (1998) Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation. Respiration 65: 199-204. PMID: 9670302
45. Pang L, Knox AJ (2000) Synergistic inhibition by β2-agonists and corticosteroids on tumor necrosis factor-α-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 23: 79-85. PMID: 10873156
46. Kamide T, Okumura S, Ghosh S, Shinoda Y, Mototani Y, Ohnuki Y, et al. (2015) Oscillation of cAMP and Ca2+ in cardiac myocytes: a systems biology approach. J Physiol Sci 65: 195-200. doi: 10.1007/s12576-014-0354-3 PMID: 25585963
47. Feng Y, Lu S, Wang J, Kumar P, Zhang L, Bhatt AJ (2014) Dexamethasone-induced neuroprotection in hypoxic-ischemic brain injury in newborn rats is partly mediated via Akt activation. Brain Res 1589c: 68-77. doi: 10.1016/j.brainres.2014.09.073 PMID: 25304361
48. Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda S, et al. (2011) Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13: 170-182. doi: 10.1016/j.cmet.2011.01.001 PMID: 21284984
49. Kawakami E, Kawai N, Kinouchi N, Mori H, Ohsawa Y, Ishimaru N, et al. (2013) Local applications of myostatin-siRNA with atelocollagen increase skeletal muscle mass and recovery of muscle function. PLoS One 8: e64719. doi: 10.1371/journal.pone.0064719 PMID: 23717655